التفاصيل البيبلوغرافية
| العنوان: |
Patent Application Titled "Methods Of Treating Cancer With An Mtor Inhibitor" Published Online (USPTO 20240082249). |
| المصدر: |
Cancer Weekly; 4/2/2024, p1731-1731, 1p |
| مصطلحات موضوعية: |
PATENT applications, MTOR inhibitors, INTERNET publishing, COENZYMES |
| مستخلص: |
A patent application has been published online for a method of treating cancer using an mTOR inhibitor called RMC-5552. The inventors propose administering the compound to a subject at a dosage ranging from 3 mg/week to 25 mg/week. They suggest that this method is effective and well-tolerated for cancer treatment. The application also discusses the need for new treatment options for cancers with dysregulated PI3K/mTOR signaling and for subjects with acquired resistance to current targeted therapies. Additionally, the application describes the use of a tacrolimus solution in the treatment or prevention of mucositis in subjects being treated with an mTOR inhibitor. The methods and compounds described in the application can be used to treat various types of cancer, including bladder cancer, breast cancer, colorectal cancer, and more. [Extracted from the article] |
|
Copyright of Cancer Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
